Commentary on: Borrows DL, Hagardorn AN, Harlan GC, Wallen EDB, Ferslew KE. A fatal drug interaction between oxycodone and clonazepam. J Forensic Sci 2003;48(3):683-86.

    Volume 49, Issue 3 (May 2004)

    ISSN: 0022-1198

    CODEN: JFSOAD

    Published Online: 10 March 2004

    Page Count: 1


    Abstract

    Sir: This letter is in response to information published within a case report written by David L. Burrows et al. in the May 2003 issue of J Forensic Sci (1). We credit the authors for bringing to light the potentially fatal consequence of the concomitant abuse of two central nervous system (CNS) depressant drugs, such as oxycodone and clonazepam, as there may be an under-appreciation of such a risk. The risk of fatal overdose is indeed substantially increased when opioids are abused in combination with other CNS active drugs (2). However, in the article, titled “A fatal drug interaction between oxycodone and clonazepam,” the authors provide a table with OxyContin® (oxycodone HCl controlled-release) pharmacokinetic and dosage information (Table 1) that is inaccurate and potentially misleading.


    Paper ID: JFS2003344

    DOI: 10.1520/JFS2003344

    ASTM International
    is a member of CrossRef.

    Author
    Title Commentary on: Borrows DL, Hagardorn AN, Harlan GC, Wallen EDB, Ferslew KE. A fatal drug interaction between oxycodone and clonazepam. J Forensic Sci 2003;48(3):683-86.
    Symposium , 0000-00-00
    Committee E30